153 related articles for article (PubMed ID: 32178718)
41. Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation.
Georgel PT; Horowitz-Scherer RA; Adkins N; Woodcock CL; Wade PA; Hansen JC
J Biol Chem; 2003 Aug; 278(34):32181-8. PubMed ID: 12788925
[TBL] [Abstract][Full Text] [Related]
42. MeCP2 preferentially binds to methylated linker DNA in the absence of the terminal tail of histone H3 and independently of histone acetylation.
Ishibashi T; Thambirajah AA; Ausió J
FEBS Lett; 2008 Apr; 582(7):1157-62. PubMed ID: 18339321
[TBL] [Abstract][Full Text] [Related]
43. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
Buschdorf JP; Strätling WH
J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
[TBL] [Abstract][Full Text] [Related]
44. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
[TBL] [Abstract][Full Text] [Related]
45. Potential role of DNA methylation as a facilitator of target search processes for transcription factors through interplay with methyl-CpG-binding proteins.
Kemme CA; Marquez R; Luu RH; Iwahara J
Nucleic Acids Res; 2017 Jul; 45(13):7751-7759. PubMed ID: 28486614
[TBL] [Abstract][Full Text] [Related]
46. Structural analyses reveal that MBD3 is a methylated CG binder.
Liu K; Lei M; Wu Z; Gan B; Cheng H; Li Y; Min J
FEBS J; 2019 Aug; 286(16):3240-3254. PubMed ID: 30980593
[TBL] [Abstract][Full Text] [Related]
47. Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.
Müller-Tidow C; Kügler K; Diederichs S; Klümpen S; Möller M; Vogt U; Metzger R; Schneider PM; Berdel WE; Serve H
Br J Cancer; 2001 Oct; 85(8):1168-74. PubMed ID: 11710831
[TBL] [Abstract][Full Text] [Related]
48. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
[TBL] [Abstract][Full Text] [Related]
49. MeCP2 Binding Cooperativity Inhibits DNA Modification-Specific Recognition.
Khrapunov S; Tao Y; Cheng H; Padlan C; Harris R; Galanopoulou AS; Greally JM; Girvin ME; Brenowitz M
Biochemistry; 2016 Aug; 55(31):4275-85. PubMed ID: 27420643
[TBL] [Abstract][Full Text] [Related]
50. Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation.
Brero A; Easwaran HP; Nowak D; Grunewald I; Cremer T; Leonhardt H; Cardoso MC
J Cell Biol; 2005 Jun; 169(5):733-43. PubMed ID: 15939760
[TBL] [Abstract][Full Text] [Related]
51. The Ski protein family is required for MeCP2-mediated transcriptional repression.
Kokura K; Kaul SC; Wadhwa R; Nomura T; Khan MM; Shinagawa T; Yasukawa T; Colmenares C; Ishii S
J Biol Chem; 2001 Sep; 276(36):34115-21. PubMed ID: 11441023
[TBL] [Abstract][Full Text] [Related]
52. Neuronal non-CG methylation is an essential target for MeCP2 function.
Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
[TBL] [Abstract][Full Text] [Related]
53. Absence of MeCP2 binding to non-methylated GT-rich sequences in vivo.
Connelly JC; Cholewa-Waclaw J; Webb S; Steccanella V; Waclaw B; Bird A
Nucleic Acids Res; 2020 Apr; 48(7):3542-3552. PubMed ID: 32064528
[TBL] [Abstract][Full Text] [Related]
54. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2).
Di Fiore B; Palena A; Felsani A; Palitti F; Caruso M; Lavia P
Nucleic Acids Res; 1999 Jul; 27(14):2852-9. PubMed ID: 10390525
[TBL] [Abstract][Full Text] [Related]
55. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
Patra SK; Patra A; Zhao H; Carroll P; Dahiya R
Biochem Biophys Res Commun; 2003 Mar; 302(4):759-66. PubMed ID: 12646234
[TBL] [Abstract][Full Text] [Related]
56. 5-hydroxymethylcytosine accumulation in postmitotic neurons results in functional demethylation of expressed genes.
Mellén M; Ayata P; Heintz N
Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7812-E7821. PubMed ID: 28847947
[TBL] [Abstract][Full Text] [Related]
57. Role of base excision repair in maintaining the genetic and epigenetic integrity of CpG sites.
Bellacosa A; Drohat AC
DNA Repair (Amst); 2015 Aug; 32():33-42. PubMed ID: 26021671
[TBL] [Abstract][Full Text] [Related]
58. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
Esfandiari F; Green R; Cotterman RF; Pogribny IP; James SJ; Miller JW
Carcinogenesis; 2003 Dec; 24(12):1935-40. PubMed ID: 12949043
[TBL] [Abstract][Full Text] [Related]
59. MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase.
Tatematsu KI; Yamazaki T; Ishikawa F
Genes Cells; 2000 Aug; 5(8):677-88. PubMed ID: 10947852
[TBL] [Abstract][Full Text] [Related]
60. Reading the unique DNA methylation landscape of the brain: Non-CpG methylation, hydroxymethylation, and MeCP2.
Kinde B; Gabel HW; Gilbert CS; Griffith EC; Greenberg ME
Proc Natl Acad Sci U S A; 2015 Jun; 112(22):6800-6. PubMed ID: 25739960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
